Article
Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE.
Neurobiology of aging - 1 Sept 2007
Björk Behnosh F, Katzov Hagit, Kehoe Patrick, Fratiglioni Laura, Winblad Bengt, Prince Jonathan A, Graff Caroline
Abstract excerpt
Insulin degrading enzyme (IDE) is one of the principal proteases involved in the degradation of the beta-amyloid peptide, which is the major constituent of senile plaques in Alzheimer's disease (AD) brains. Previous association studies between AD and IDE have produced inconsistent results which may be indicative of a need for larger case-control series to identify what may be a relatively small effect size. Thus,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
